Interventions for Bipolar Disorders

Refine your search

Age Cohort
Public Health Function
Level of Care
Published Evidence
Download:

Filtering by:

 
Age Cohort: 25 - 59 years
Health Promotion Disease Prevention Diagnostic Curative Rehabilitative Palliative
Community Level
  • Community engagement [community sensitization on bipolar disorder, healthy diets, exercise]
  • Education directed at elimination of stigmatization of people living with mental health conditions Provision of IEC/BCC materials
  • Promote functioning in activities of daily living and rehabilitation and inclusion in the community
  • Early recognition of the need for referral
Primary Care
  • Assessment for symptoms of anxiety
  • Referral to the next level for specialized mental health investigation
Referral Facility: General
  • History and physical examination for bipolar disorder
  • Basic laboratory tests
  • Assessment of self-harm and suicide risk in people with mental, neurological, and substance use conditions
  • Promote functioning in activities of daily living and rehabilitation and inclusion in the community
  • Psychoeducation and psychosocial support (including for patient’s carers)
  • Provide cognitive behavioural therapy or interpersonal therapy for bipolar disorders
  • Oral anticholinergic medications for drug induced extrapyramidal side effects
  • Oral lithium for bipolar disorder
  • Oral antipsychotics for bipolar disorder
  • Oral anticonvulsants for bipolar disorder
  • Intravenous long-acting benzodiazepine for bipolar disorder
  • Monitoring of lithium and other mood stabilizers and antipsychotic medicines
Referral Facility: Specialist
  • History and physical examination for bipolar disorder
  • Basic laboratory tests
  • Assessment of self-harm and suicide risk in people with mental, neurological, and substance use conditions
  • Promote functioning in activities of daily living and rehabilitation and inclusion in the community
  • Psychoeducation and psychosocial support (including for patient’s carers)
  • Provide cognitive behavioural therapy or interpersonal therapy for bipolar disorders
  • Oral anticholinergic medications for drug induced extrapyramidal side effects
  • Oral lithium for bipolar disorder
  • Oral antipsychotics for bipolar disorder
  • Oral anticonvulsants for bipolar disorder
  • Intravenous long-acting benzodiazepine for bipolar disorder
  • Monitoring of lithium and other mood stabilizers and antipsychotic medicines
 
Age Cohort: 60+ years
Health Promotion Disease Prevention Diagnostic Curative Rehabilitative Palliative
Community Level
  • Community engagement [community sensitization on bipolar disorder, healthy diets, exercise]
  • Education directed at elimination of stigmatization of people living with mental health conditions Provision of IEC/BCC materials
  • Encourage compliance with medications
  • Promote functioning in activities of daily living and rehabilitation and inclusion in the community
  • Early recognition of the need for referral
Primary Care
  • Assessment for symptoms of anxiety
  • Referral to the next level for specialized mental health investigation
Referral Facility: General
  • Psychoeducation and psychosocial support (including for patient’s carers)
  • Provide cognitive behavioural therapy or interpersonal therapy for bipolar disorders
  • Oral anticholinergic medications for drug induced extrapyramidal side effects
  • Oral lithium for bipolar disorder
  • Oral antipsychotics for bipolar disorder
  • Oral anticonvulsants for bipolar disorder
  • Intravenous long-acting benzodiazepine for bipolar disorder
  • Monitoring of lithium and other mood stabilizers and antipsychotic medicines
Referral Facility: Specialist
  • Cognitive behavioural therapy or interpersonal therapy for bipolar disorders
  • Oral anticholinergic medications for drug induced extrapyramidal side effects
  • Oral lithium for bipolar disorder
  • Oral antipsychotics for bipolar disorder
  • Oral anticonvulsants for bipolar disorder
  • Intravenous long-acting benzodiazepine for bipolar disorder
  • Monitoring of lithium and other mood stabilizers and antipsychotic medicines
 
Age Cohort: 12 - 24 years
Health Promotion Disease Prevention Diagnostic Curative Rehabilitative Palliative
Community Level
  • Community engagement [community sensitization on psychiatric disorders, healthy diets, exercise, stress management, healthy relationships]
  • Education directed at elimination of stigmatization of people living with mental health conditions
  • Early identification of the warning signs of an approaching episode to seek early treatment
  • Recognition signs and symptoms of mental health disorders
  • Early identification and referral
  • Regular social, educational and occupational support
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • Linkage to address financial well-being of patients and family members
Primary Care
  • Education of patients and families on medication compliance, the various symptoms and signs of the disorder
  • Early identification of the warning signs of an approaching episode to seek early treatment
  • Recognition signs and symptoms of mental health disorders
  • Psychoeducation
  • cognitive behavioural therapy (CBT)
  • Family-focused therapy
  • Regular social, educational and occupational support
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • Linkage to address financial well-being of patients and family members
Referral Facility: General
  • Education of patients and families on medication compliance, the various symptoms and signs of the disorder
  • History
  • Physical examination
  • Psychiatric assessment
  • Mood stabilizers (e.g. Lithium)
  • Antipsychotics
  • Combination therapy (mood stabilizer and antipsychotics)
  • Electroconvulsive therapy
  • Psychoeducation
  • cognitive behavioural therapy (CBT)
  • Interpersonal and social rhythm therapy (IPSRT)
  • Family-focused therapy
  • Monitor drug adverse effects
  • Regular social, educational and occupational support
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • Linkage to address financial well-being of patients and family members
Referral Facility: Specialist
  • Education of patients and families on medication compliance, the various symptoms and signs of the disorder
  • History
  • Physical examination
  • Psychiatric assessment
  • Mood stabilizers
  • Antipsychotics
  • Atypical antipsychotics
  • Combination therapy (mood stabilizer and antipsychotics)
  • Electroconvulsive therapy
  • Psychoeducation
  • cognitive behavioural therapy (CBT)
  • Interpersonal and social rhythm therapy (IPSRT)
  • Family-focused therapy
  • Monitor drug adverse effects
  • Regular social, educational and occupational support
  • Emotional, social, spiritual assessment and support based on cultural needs, values and preferences of patients and families
  • Linkage to address financial well-being of patients and family members